Cargando…

Hormone receptor status may impact the survival benefit of surgery in stage IV breast cancer: a population-based study

INTRODUCTION: The role of surgery in stage IV breast cancer is controversial. We used the Surveillance, Epidemiology, and End Results database to explore the impact of surgery on the survival of patients with stage IV breast cancer. METHODS: In total, 10,441 eligible stage IV breast cancer patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Yinuo, Li, Xiaofen, Chen, Haiyan, Hu, Yeting, Jiang, Mengjie, Fu, Jianfei, Yuan, Ying, Ding, Kefeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342604/ https://www.ncbi.nlm.nih.gov/pubmed/27542240 http://dx.doi.org/10.18632/oncotarget.11235

Ejemplares similares

A Minor (<50%) Signet-Ring Cell Component Associated with Poor Prognosis in Colorectal Cancer Patients: A 26-Year Retrospective Study in China
por: Tan, Yinuo, et al.
Publicado: (2015)

Neuroendocrine differentiation is predictive of poor survival in patients with stage II colorectal cancer
por: Liu, Yue, et al.
Publicado: (2017)

Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms
por: Jiang, Mengjie, et al.
Publicado: (2017)

Silencing of brain-expressed X-linked 2 (BEX2) promotes colorectal cancer metastasis through the Hedgehog signaling pathway
por: Tan, Yinuo, et al.
Publicado: (2020)

Survival benefits of gastrectomy in gastric cancer patients with stage IV: a population-based study
por: He, Xingkang, et al.
Publicado: (2017)

BEX2 promotes tumor proliferation in colorectal cancer
por: Hu, Yeting, et al.
Publicado: (2017)

ANGPTL1 attenuates colorectal cancer metastasis by up-regulating microRNA-138
por: Chen, Haiyan, et al.
Publicado: (2017)

Survival benefit of adjuvant radiotherapy in stage III and IV bladder cancer: results of 170 patients
por: Bayoumi, Yasser, et al.
Publicado: (2014)

A 10-year Population-based Study of the Differences between NECs and Carcinomas of the Esophagus in Terms of Clinicopathology and Survival
por: Cai, Wen, et al.
Publicado: (2019)

The survival benefits of local surgery in stage IV breast cancer are not affected by breast cancer subtypes: a population-based analysis
por: Wu, San-Gang, et al.
Publicado: (2017)

Synchronous Resectable Metastatic Colorectal Cancer: Lymph Node Involvement Predicts Poor Outcome
por: Fu, Jianfei, et al.
Publicado: (2015)

Hormone Receptor Status May Impact the Survival Benefit Between Medullary Breast Carcinoma and Atypical Medullary Carcinoma of the Breast: A Population-Based Study
por: Qin, Wenxing, et al.
Publicado: (2021)

Combining chemotherapy and autologous peptide‐pulsed dendritic cells provides survival benefit in stage IV melanoma patients
por: Eisendle, Klaus, et al.
Publicado: (2020)

Metastatic Pattern Discriminates Survival Benefit of Type of Surgery in Patients With De Novo Stage IV Breast Cancer Based on SEER Database
por: Li, Kunlong, et al.
Publicado: (2021)

Accuracy of Magnetic Resonance Imaging in Staging Rectal Cancer with Multidisciplinary Team: A Single-Center Experience
por: Yu, Linzhen, et al.
Publicado: (2019)

Association of Insurance Status and Extent of Organ Involvement With Survival Among Patients With Stage IV Cancer
por: Zhan, Peter L., et al.
Publicado: (2022)

Impact of Primary Site Surgery on Survival of Patients with de novo Stage IV Breast Cancer
por: Huang, Zhen, et al.
Publicado: (2021)

Survival benefit of surgical resection for stage IV gastric cancer: A SEER-based propensity score-matched analysis
por: Sun, Jianhui, et al.
Publicado: (2022)

Survival benefit of radiotherapy after surgery in de novo stage IV breast cancer: a population-based propensity-score matched analysis
por: Kim, Yi-Jun, et al.
Publicado: (2019)

Predicting the survival benefit of local surgery in patients aged 70 years or older with stage IV breast cancer: A population-based analysis
por: Chen, Yu-qiu, et al.
Publicado: (2021)

Incidence, Surgical Treatment, and Prognosis of Anorectal Melanoma From 1973 to 2011: A Population-Based SEER Analysis
por: Chen, Haiyan, et al.
Publicado: (2016)

CHIS Rules_List of benefits- Annexes I, II,IV - 01 May 2023
por: Wanert-Calaga, Sophie Marie
Publicado: (2023)

Pattern and risk factors for distant metastases in gastrointestinal neuroendocrine neoplasms: a population‐based study
por: Cai, Wen, et al.
Publicado: (2018)

Relative Survival Benefit by Hormonal Receptor Status of Adding Trastuzumab to Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Schneider, Jean, et al.
Publicado: (2020)

Postmastectomy Radiotherapy Improves Survival Benefits in De Novo Stage IV Breast Cancer: A Propensity-Score Matched Analysis
por: Wang, Xiaojuan, et al.
Publicado: (2022)

Deguelin induces apoptosis in colorectal cancer cells by activating the p38 MAPK pathway
por: Chen, Liubo, et al.
Publicado: (2018)

Surgery on primary tumor shows survival benefit in selected stage IV colon cancer patients: A real-world study based on SEER database
por: Xu, Jing, et al.
Publicado: (2020)

Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients
por: Shen, Hong, et al.
Publicado: (2016)

Young Patients (≤35years old) With Colorectal Cancer Have Worse Outcomes Due to More Advanced Disease: A 30-Year Retrospective Review
por: Fu, Jianfei, et al.
Publicado: (2014)

Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit
por: Sun, Duxin
Publicado: (2020)

Radiotherapy for stage IIA rectal cancer may not benefit all
por: Hu, Xiang, et al.
Publicado: (2017)

Could local surgery improve survival in de novo stage IV breast cancer?
por: Xiong, Zhenchong, et al.
Publicado: (2018)

Nomograms to predict survival of stage IV tongue squamous cell carcinoma after surgery
por: Sun, Wei, et al.
Publicado: (2019)

Survival Outcomes after Elective or Emergency Surgery for Synchronous Stage IV Colorectal Cancer
por: Mun, Ji-Yeon, et al.
Publicado: (2022)

Predictors and Risk Factors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Population-Based Analysis
por: Tan, Yinuo, et al.
Publicado: (2019)

Development and validation of nomogram models to predict radiotherapy or chemotherapy benefit in stage III/IV gastric adenocarcinoma with surgery
por: Ren, Xiangqing, et al.
Publicado: (2023)

Primary Tumor Resection in Stage IV Breast Cancer: Consistent Benefit, or Consistent Bias?
por: Khan, Seema A.
Publicado: (2007)

Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit
por: Sun, Duxin
Publicado: (2020)

Neuroendocrine Differentiation Is a Prognostic Factor for Stage II Poorly Differentiated Colorectal Cancer
por: Liu, Yue, et al.
Publicado: (2014)

Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer
por: Yang, Hai-Yuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ikinonf8gsm9fu5vpd694tpoeb